How data is letting corporations wring every penny from your purchases.
Phillip Longman
Phil joined the staff of the Washington Monthly in 2012. He is also the policy director at the Open Markets Institute and a lecturer at Johns Hopkins, where he teaches health care policy.
In addition to writing many feature articles for the Monthly, Phil’s work has appeared in such publications as The Atlantic Monthly, The Financial Times, Foreign Affairs, Foreign Policy, Harvard Business Review, The New Republic, The New Statesman, The New York Times Magazine, Politica Exterior, Der Spiegel, and World Politics Review. He is a graduate of Oberlin College, and was also a Knight-Bagehot Fellow at Columbia University.
Phil is on X @LongmanPhil.
The Case For Small-Business Cooperation
How America’s anti-monopoly laws got turned against the little guy.
Can Big Medicine Control Big Pharma? (Hint: the Answer Is ‘No’)
Four giant health care systems are joining forces to produce generic drugs at a lower cost to themselves. But, that doesn’t mean the savings will be passed on to consumers.
How Big Medicine Can Ruin Medicare for All
A single-payer system will degenerate into corporate welfare unless we take on health care monopolies.
More Fake News about VA Hospitals
This time, the hapless New York Times is the culprit.
How to Make Conservatism Great Again
To save their party from Trumpism, Republicans need to once again take on monopolists.
Bloom and Bust
Regional inequality is out of control. Here’s how to reverse it.
Wealth and Generations
By focusing on the growing riches of the “1 percent,” we miss another form of inequality that is bigger, and arguably even more dangerous.
Lost in Obamacare
Buried in Steven Brill’s convoluted tome are important truths about how to reform our health care delivery system.
The American Way of Dying
How our refusal to face up to the realities of aging and mortality causes needless suffering.

